<PAGE>
Exhibit 23.2
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the reference to our firm under the caption "Experts" in Amendment
No. 2 to the Registration Statement (Form S-3 No. 333-37742) and related
Prospectus of COR Therapeutics, Inc. for the registration of $300 million of 5%
convertible subordinated notes due March 1, 2007, and 8,881,680 shares of its
common stock issuable upon conversion of the notes, and to the incorporation by
reference therein of our report dated January 20, 2000, with respect to the
financial statements of COR Therapeutics, Inc. included in its Annual Report
(Form 10-K) for the year ended December 31, 1999, filed with the Securities and
Exchange Commission.
/s/ ERNST & YOUNG LLP
Palo Alto, California
August 18, 2000
